Skip to content

Study · Not a test of the peptide alone · 2014

1 result

Secreted calmodulin-like skin protein ameliorates scopolamine-induced memory impairment.

Hayashi M, Tajima H, Hashimoto Y, Matsuoka M

Neuroreport1 Jun 2014Cited by 7 (Europe PMC)

PMID23797156 (opens in a new tab)DOI10.1097/wnr.0b013e328362d9fe (opens in a new tab)PepBankPUB-23797156
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Humanin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Humanin.

  1. 01AnimalNot a test of Humanin aloneAnimal study (in vivo)Efficacy outcome

    In mice, recombinant calmodulin-like skin protein (CLSP), given intracerebroventricularly or intraperitoneally, ameliorated scopolamine-induced dementia.

    In plain wordsIn mice, a skin protein called CLSP, not humanin itself, reduced memory problems caused by scopolamine.

    Peptide
    Humanin
    Outcome
    DecreaseScopolamine-induced memory impairment
    Study

    mousen: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition

    Source sentences

    Summary
    In this study, we show that recombinant CLSP, administered intracerebroventricularly or intraperitoneally, ameliorates scopolamine-induced dementia in mice.
    1 context sentence
    Summary · context
    However, it remains unknown whether CLSP ameliorates memory impairment in mouse dementia models as Humanin does.

    In this study, Humanin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Humanin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.